Exact Sciences CorporationEXASNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
7.70%
↓ 78% below average
Average (39q)
35.11%
Historical baseline
Range
High:1318.45%
Low:-74.11%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 7.70% |
| Q2 2025 | 3.41% |
| Q1 2025 | 5.71% |
| Q4 2024 | -1.84% |
| Q3 2024 | -16.23% |
| Q2 2024 | 9.27% |
| Q1 2024 | -3.53% |
| Q4 2023 | 3.12% |
| Q3 2023 | 7.06% |
| Q2 2023 | 9.09% |
| Q1 2023 | 1.21% |
| Q4 2022 | 3.81% |
| Q3 2022 | -14.39% |
| Q2 2022 | 3.75% |
| Q1 2022 | 15.55% |
| Q4 2021 | 17.43% |
| Q3 2021 | -29.07% |
| Q2 2021 | -8.07% |
| Q1 2021 | -74.11% |
| Q4 2020 | 1318.45% |
| Q3 2020 | -3.68% |
| Q2 2020 | -24.91% |
| Q1 2020 | 2.30% |
| Q4 2019 | 21.71% |
| Q3 2019 | 15.70% |
| Q2 2019 | -5.66% |
| Q1 2019 | 52.95% |
| Q4 2018 | 18.72% |
| Q3 2018 | 19.84% |
| Q2 2018 | -1.49% |
| Q1 2018 | 17.83% |
| Q4 2017 | 8.10% |
| Q3 2017 | 20.42% |
| Q2 2017 | 21.68% |
| Q1 2017 | 12.99% |
| Q4 2016 | -7.12% |
| Q3 2016 | -11.75% |
| Q2 2016 | -14.68% |
| Q1 2016 | 8.13% |
| Q4 2015 | -5.05% |